Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 30Peritoneal Neoplasms 24Ovarian Neoplasms 24Fallopian Tube Neoplasms 13Carcinoma, Ovarian Epithelial 12Colorectal Neoplasms 11Neoplasm Metastasis 5Appendiceal Neoplasms 5Recurrence 3Pancreatic Neoplasms 3Neoplasms 3Uterine Neoplasms 2Sarcoma 2Pseudomyxoma Peritonei 2Mesothelioma 2Hyperthermic Intraperitoneal Chemotherapy 2Gastric Adenocarcinoma 2Desmoplastic Small Round Cell Tumor 2Colonic Neoplasms 2Carcinoma 2Wilms Tumor 1Uterine Cervical Neoplasms 1Stage â…¢ Gastric Cancer 1Rhabdomyosarcoma 1Rectal Neoplasms 1Peritoneal Metastases From Gastric Cancer 1Peritoneal Metastases From Colorectal Cancer 1Peritoneal Diseases 1Pelvic Neoplasms 1Ovarian Epithelial Cancer Recurrent 1

Interventions

camrelizumab 3Oxaliplatin 3apatinib 2S 1 (combination) 2Capecitabine 2XELOX 1Taxes 1Laparoscopy 1Hyperthermic Intraperitoneal Chemotherapy 1Gastrectomy 1Conversion to Open Surgery 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Locally Advanced Gastric Cancer × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT07621484 2026-06-02

HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer

Shanghai Changzheng Hospital

Phase 2 Not yet recruiting
48 enrolled
Gastrointestinal

Locally Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡